Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease
Cardiology and Cardiovascular Medicine · 2026 · 10 (2)
DOI: 10.26502/fccm.92920485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology and Cardiovascular Medicine, 2026. Verfasst von Meghana Kaipa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research, Western University of Health Sciences, Pomona, California, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Research, Western University of Health Sciences, Pomona, California, USA.
Förderung
- NIAID NIH HHS
Zitieren
APA
Kaipa, M., & Agrawal, D. K. (2026). Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease. Cardiology and Cardiovascular Medicine, 10(2). https://doi.org/10.26502/fccm.92920485
Vancouver
Kaipa M, Agrawal DK. Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease. Cardiology and Cardiovascular Medicine. 2026;10(2). doi:10.26502/fccm.92920485
BibTeX
@article{Kaipa2026,
author = {Kaipa, Meghana and Agrawal, Devendra K},
title = {Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease},
journal = {Cardiology and Cardiovascular Medicine},
year = {2026},
volume = {10},
number = {2},
doi = {10.26502/fccm.92920485}
}
EUVIMED